lamivudine has been researched along with Enterocolitis, Necrotizing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eilers, E; Feiterna-Sperling, C; Obladen, M; Schmitz, T; Weizsaecker, K | 1 |
| Calhoun, DA; Christensen, RD; Juul, SE; McBryde, EV; Veerman, MW | 1 |
2 other study(ies) available for lamivudine and Enterocolitis, Necrotizing
| Article | Year |
|---|---|
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine; Male; Nevirapine; Risk Factors; Zidovudine | 2006 |
Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.
Topics: Cold Temperature; Drug Stability; Drug Therapy; Enterocolitis, Necrotizing; Enzyme-Linked Immunosorbent Assay; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Lamivudine; Recombinant Proteins | 2000 |